About Advanced PrecisionMed Solutions Limited
Advanced PrecisionMed Solutions Limited is a UAE-based healthcare technology and precision medicine company dedicated to advancing digital health, genomic innovation and data-driven healthcare solutions. Operating from Dubai, the organisation supports healthcare providers, research institutions and life-science partners through secure digital platforms, precision medicine services and advanced healthcare technologies. The company places patient privacy, information security and ethical data governance at the centre of its operations, implementing internationally recognised practices to safeguard sensitive health information throughout the data lifecycle. By combining innovation with robust governance, Advanced PrecisionMed Solutions enables healthcare organisations to leverage medical data responsibly while maintaining confidentiality, regulatory compliance and public trust.
Outcome overview
The privacy-by-design framework has strengthened the organisation’s ability to manage sensitive healthcare information through a coordinated combination of governance, risk management, technical controls and workforce accountability.
Improved accountability
Privacy responsibilities are more clearly incorporated into organisational decision-making. Defined roles, approval arrangements and escalation processes support stronger accountability for information collection, access, use, sharing and protection.
Relevant evidence may include:
Approved privacy and information security policies.
Governance structures and responsibility matrices.
Management or committee meeting records.
Processing approval and risk-acceptance records.
Better visibility of information-processing risks
The organisation’s structured assessment approach enables privacy considerations to be identified earlier in projects, system developments and third-party arrangements. This supports informed decisions before sensitive information is introduced into a new process or technology environment.
Evidence may include:
Privacy impact or risk assessments.
Information asset and processing registers.
Project review checklists.
Risk-treatment plans and action trackers.
Stronger access and confidentiality safeguards
Role-based access, approval controls, authentication, confidentiality requirements and periodic reviews help reduce the possibility of inappropriate access to sensitive information.
Evidence may include:
Access-control matrices.
User-access approval records.
Periodic access-review results.
Confidentiality agreements.
System logs and security monitoring records.
More consistent privacy-by-design practices
The integration of privacy requirements into service and technology development helps ensure that data minimisation, secure settings, retention, access and information-sharing controls are considered systematically.
Evidence may include:
Design and change-management procedures.
Secure-development requirements.
System architecture or data-flow records.
Pre-deployment review and approval documents.
Testing and vulnerability-management records.
Improved third-party oversight
The framework strengthens the review and management of external parties that may handle, host, transmit or otherwise access sensitive information.
Evidence may include:
Supplier due-diligence assessments.
Data-processing or confidentiality agreements.
Security questionnaires.
Supplier risk classifications.
Periodic supplier review records.
Increased workforce awareness
Training and communication improve personnel understanding of confidentiality obligations, secure information handling, incident reporting and privacy responsibilities.
Evidence may include:
Training plans and attendance records.
Awareness materials.
Assessment or acknowledgement records.
Incident-reporting guidance.
Enhanced incident readiness
Defined reporting, investigation, containment and escalation arrangements enable the organisation to respond more consistently to suspected privacy or cybersecurity events.
Evidence may include:
Incident-response procedures.
Incident registers and investigation records.
Simulation or testing results.
Corrective-action records.
Lessons-learned reviews.
Stronger stakeholder confidence
By demonstrating that privacy is embedded within governance and system design, the initiative supports confidence among healthcare organisations, partners and other stakeholders considering collaboration with Advanced PrecisionMed Solutions.
Relevant evidence may include client due-diligence outcomes, completed security assessments, contractual approvals, stakeholder feedback and successful onboarding or partnership reviews.
To further demonstrate quantified impact, the organisation should present verified results where available, such as:
Percentage of personnel completing privacy training.
Percentage of critical access reviews completed on schedule.
Number of privacy assessments completed before project approval.
Percentage of high-risk suppliers assessed.
Closure rate for privacy and security actions.
Incident response and resolution times.
Reduction in overdue access removals or unresolved control findings.
Percentage of systems covered by documented retention and access requirements.
The initiative’s impact is therefore reflected not only through individual policies or technology controls, but through a more mature operating model in which privacy risks are identified, owned, monitored and addressed throughout the information lifecycle.